Robinson Chandler bought MNPR
January 28, 2025 · Form 4 insider transaction
Robinson Chandler bought 62,815 shares of Monopar Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 367 days after the transaction.
Direction
Acquired (buy-side)
Shares
62,815
Price
$0.00
Total value
N/A
InsiderRobinson Chandler
Role—
SecurityCommon Stock
Transaction codeJ: J
Transaction dateJanuary 28, 2025
Filing dateJanuary 30, 2026
Shares owned after62,815
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Pro rata liquidating distribution from Tactic Pharma, LLC ("Tactic"), of which the reporting person is a non-controlling member. In prior reports, the reporting person reported beneficial ownership of 272,026 shares of Monopar Therapeutics Inc. common stock held by Tactic.; Represents shares held by the Chandler D. Robinson Irrevocable Trust U/A dated May 20, 2020.